Biomarkers: hopes and challenges in the path from discovery to clinical practice.
about
Obesity, metabolic dysfunction, and cardiac fibrosis: pathophysiological pathways, molecular mechanisms, and therapeutic opportunitiesDetection of tumor cell-specific mRNA and protein in exosome-like microvesicles from blood and salivaGene expression profiling in human lung development: an abundant resource for lung adenocarcinoma prognosis.The inflammatory response in myocardial injury, repair, and remodelling.Cancer biomarker discovery using DNA aptamers.The extracellular matrix modulates fibroblast phenotype and function in the infarcted myocardiumFibroblasts in post-infarction inflammation and cardiac repair.Targeting inflammatory pathways in myocardial infarction.Plasma Macrophage Migration Inhibitor Factor Is Elevated in Response to Myocardial Ischemia.Perioperative utility of goal-directed therapy in high-risk cardiac patients undergoing coronary artery bypass grafting: "A clinical outcome and biomarker-based study"Clinical proteomic biomarkers: relevant issues on study design & technical considerations in biomarker development.Fibroblasts in myocardial infarction: a role in inflammation and repair.Flow cytometry: a flexible tool for biomarker research.Targeting the chemokines in cardiac repair.The immune system and the remodeling infarcted heart: cell biological insights and therapeutic opportunities.Biomarkers in the assessment of acute and chronic kidney diseases in the dog and cat.Microfluidic platforms for biomarker analysis.Inflammation as a therapeutic target in myocardial infarction: learning from past failures to meet future challenges.Interleukin-1 in cardiac injury, repair, and remodeling: pathophysiologic and translational conceptsPathophysiology of Myocardial Infarction.Comparison between male and female Sprague-Dawley rats in the response of urinary biomarkers to injury induced by gentamicin.Re-employment, job quality, health and allostatic load biomarkers: prospective evidence from the UK Household Longitudinal Study.Can Astrocytes Be a Target for Precision Medicine?Bioapplications of Cell-SELEX-Generated Aptamers in Cancer Diagnostics, Therapeutics, Theranostics and Biomarker Discovery: A Comprehensive Review.Periostin: a novel tissue biomarker correlates with chronicity index and renal function in lupus nephritis patients.
P2860
Q26825697-0C2F6369-E576-4EB7-9BAB-A24A1C6D4960Q34513049-E1075561-B1A8-4E0D-A005-55257F36940DQ35228753-7C59EC73-4A58-42BA-8B48-161F34691622Q35529656-8978CC6B-8B78-44DA-BFD0-70C36FFD3B25Q36430991-2FE02F70-FA3C-4CE6-A650-A086FA7317D1Q36502326-F272A84F-DE60-42FC-8546-33EEB40A5836Q36522008-5EA0880C-CAC0-49E5-AF44-E87D3EC36B77Q37100838-07A9D147-C097-438D-8614-00AE430FAD28Q37240620-5E92AD86-BF7D-4E4E-A759-2F8B981783BDQ37350366-8345C76D-8439-4B5B-87F5-B0CBB211F8F6Q37714579-49479519-6B83-4863-A917-1FEBCD513099Q37716851-BF05A74F-F2C4-408B-A6BD-DF4438A0CD9DQ38060201-17D96819-BCEB-4840-BD9A-0390435AB5A4Q38120799-9981E76E-16E2-4FD5-A6A2-D417D5BCB3D3Q38144845-7A85769B-93FE-462B-9502-88B27C4A817EQ38154953-1BFD5B7E-4494-4F04-B6D4-E15F9148D123Q38198962-607D7DE3-4AED-4DF6-8122-68A5E71C436BQ38560476-B866B630-A319-4E78-9A88-18C202BEA15DQ38566665-2A83823F-B8A3-410C-9437-ED12ADB9A458Q38596702-7903F3DA-C546-464A-BC3F-E0CA4AB95952Q43683587-DF63A0C2-552E-4FA9-A983-49DAE3033F6AQ47657732-8EC4C4DB-426D-4266-BDCA-A0681CC116EBQ48140499-1BE16F7B-7519-4885-AFF2-EC19E22E79A6Q50099625-2A92FB7E-B702-45C8-9057-539DF82B6CE6Q52975219-B83B1BB5-1335-4DFC-A779-1D22BAE608D8
P2860
Biomarkers: hopes and challenges in the path from discovery to clinical practice.
description
2012 nî lūn-bûn
@nan
2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Biomarkers: hopes and challenges in the path from discovery to clinical practice.
@ast
Biomarkers: hopes and challenges in the path from discovery to clinical practice.
@en
type
label
Biomarkers: hopes and challenges in the path from discovery to clinical practice.
@ast
Biomarkers: hopes and challenges in the path from discovery to clinical practice.
@en
prefLabel
Biomarkers: hopes and challenges in the path from discovery to clinical practice.
@ast
Biomarkers: hopes and challenges in the path from discovery to clinical practice.
@en
P2860
P1476
Biomarkers: hopes and challenges in the path from discovery to clinical practice
@en
P2093
Nikolaos G Frangogiannis
P2860
P304
P356
10.1016/J.TRSL.2012.01.023
P577
2012-02-14T00:00:00Z